Accenture plc vs Merck & Co. Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Accenture plc (ACN) carries a "Neutral" signal with +8.3% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Technology and Healthcare sectors.
| Metric | Accenture plc (ACN) | Merck & Co. Inc. (MRK) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $18.0B | $16.3B |
| Revenue Growth | 8.3%* | -2.2% |
| Latest EPS | $2.93* | $-1.72 |
| EPS Growth | 3.9%* | -238.7% |
| Sector | Technology | Healthcare |
| Quarters Tracked | 8 | 8 |
Accenture plc (ACN) carries a "Neutral" signal with +8.3% revenue growth, while Merck & Co. Inc. (MRK) is "Neutral" with -2.2% revenue growth. Both companies report in the Technology and Healthcare sectors.